11pharmaceutical partnership
Eli Lilly Partners with InSilico for $2.75 Billion AI Drug Discovery Initiative
Eli Lilly has entered a $2.75 billion partnership with InSilico Medicine to enhance AI-driven drug discovery, promising rapid advancements in pharmaceuticals.
Eli Lilly Partners with InSilico for Revolutionary AI Drug Discovery
Eli Lilly has signed a $2.75 billion partnership with InSilico Medicine to enhance drug discovery through AI technology, marking a significant industry milestone.